Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asma Dilawari

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2023
US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast CancerPreeti Narayan, Asma Dilawari, Christy Osgood, et al.
Breast Cancer Research and Treatment|October 24, 2022
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxanePaula R Pohlmann, Deena Graham, Tianmin Wu, et al.
Cancer|June 22, 2021
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancerFilipa Lynce, Matthew J Blackburn, Rebecca Zhuo, et al.
NPJ Breast Cancer|September 26, 2017
Video intervention increases participation of black breast cancer patients in therapeutic trialsBrandi N Robinson, Antoinette F Newman, Eshetu Tefera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2024
US Food and Drug Administration Approval Summary: Capivasertib With Fulvestrant for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer With <i>PIK3CA</i>/<i>AKT1</i>/<i>PTEN</i> AlterationsAsma Dilawari, James Buturla, Christy Osgood, et al.
Journal of Pain and Symptom Management|November 26, 2018
Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer SurvivorsDanielle B Tometich, Brent J Small, Judith E Carroll, et al.
Cancer|December 21, 2019
Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) studyJeanne S Mandelblatt, Wanting Zhai, Jaeil Ahn, et al.
Breast Cancer Research and Treatment|May 19, 2022
Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer StudyJames C Root, Xingtao Zhou, Jaeil Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2023
FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian CancerAsma Dilawari, Mirat Shah, Gwynn Ison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2018
Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer StudyJeanne S Mandelblatt, Brent J Small, Gheorghe Luta, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2023
US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast CancerPreeti Narayan, Asma Dilawari, Christy Osgood, et al.
Breast Cancer Research and Treatment|October 24, 2022
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxanePaula R Pohlmann, Deena Graham, Tianmin Wu, et al.
Cancer|June 22, 2021
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancerFilipa Lynce, Matthew J Blackburn, Rebecca Zhuo, et al.
NPJ Breast Cancer|September 26, 2017
Video intervention increases participation of black breast cancer patients in therapeutic trialsBrandi N Robinson, Antoinette F Newman, Eshetu Tefera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2024
US Food and Drug Administration Approval Summary: Capivasertib With Fulvestrant for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer With <i>PIK3CA</i>/<i>AKT1</i>/<i>PTEN</i> AlterationsAsma Dilawari, James Buturla, Christy Osgood, et al.
Journal of Pain and Symptom Management|November 26, 2018
Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer SurvivorsDanielle B Tometich, Brent J Small, Judith E Carroll, et al.
Cancer|December 21, 2019
Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) studyJeanne S Mandelblatt, Wanting Zhai, Jaeil Ahn, et al.
Breast Cancer Research and Treatment|May 19, 2022
Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer StudyJames C Root, Xingtao Zhou, Jaeil Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2023
FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian CancerAsma Dilawari, Mirat Shah, Gwynn Ison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2018
Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer StudyJeanne S Mandelblatt, Brent J Small, Gheorghe Luta, et al.
Pageof 2